ITL Health Group (ASX:ITD) is pleased to announce that its wholly owned subsidiary MyHealthTest Pty Ltd (MHT), the direct to consumer pathology test provider, has launched a Thyroid TSH Test Service, with immediate effect.
According to Medicare over 5 million TSH tests are performed every year. Thyroid problems are most common in women, with about 10% of all women and up to 25% of women over 65 affected. The thyroid is a small gland in the neck that produces hormones that control metabolism.
The MyHealthTest Thyroid TSH Test Service can indicate an under-active thyroid (hypothyroidism e.g. Hashimoto’s thyroiditis). People with low thyroid levels are often prescribed medication to replace the thyroid hormones—usually taken for the rest of their life and are repeatedly monitored with repeat TSH tests.
MyHealthTest believes demand for its Thyroid TSH Test Service will come from people who find themselves tired and work out and are unable to find the time to visit the doctor to request a blood test.
MyHealthTest GM Nick Cerneaz commented “The introduction of the Thyroid TSH Test Service is an exciting step for MyHealthTest as we expand our capabilities to help customers and their doctors detect, monitor and manage chronic diseases.”
The Thyroid TSH Test Service is available through the MyHealthTest online store and will be promoted to both the existing MHT database and to new customers and health care providers. Promotional campaigns will commence in November and roll out through the first quarter of 2018.
Nick Cerneaz continued “We anticipate launching two more test services, for Prostate and Cholesterol in the very near future. These new test services will bring MyHealthTest’s portfolio to four, each seeking meet substantial pre-existing demand for more convenient testing that is used to help monitor and manage these chronic conditions.”
MyHealthTest, a highly innovative consumer-based pathology testing service, allows individuals to conveniently order the test service online, collect fingerprick samples at home, and send samples through the mail for laboratory analysis. Our next-generation pathology testing service is quality controlled to ensure accuracy and reliability, while our online portal offers guaranteed confidentiality and the simple transfer of results to healthcare practitioners or others. MyHealthTest meets the increased global demand for pathology testing services and sets the industry standard for preventative and convenient direct-to-consumer healthcare services.